JBM (Healthcare) Limited (2161.HK)
HKD 2.22
(-0.45%)
HKD 2.22
(-0.45%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 163.87 Million HKD | 34.46% |
| 2022 | 120.14 Million HKD | 13.41% |
| 2021 | 105.94 Million HKD | -3.72% |
| 2020 | 110.02 Million HKD | -24.85% |
| 2019 | 146.41 Million HKD | 39.71% |
| 2018 | 104.8 Million HKD | 10.28% |
| 2017 | 95.03 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 92.23 Million HKD | 0.0% |
| 2023 FY | 161.54 Million HKD | 34.46% |
| 2023 Q4 | 78.55 Million HKD | 0.0% |
| 2022 FY | 120.14 Million HKD | 13.41% |
| 2022 Q4 | 78.11 Million HKD | 0.0% |
| 2022 Q2 | 59.62 Million HKD | 0.0% |
| 2021 Q2 | 60.43 Million HKD | 0.0% |
| 2021 FY | 105.94 Million HKD | -3.72% |
| 2021 Q4 | 64.71 Million HKD | 0.0% |
| 2020 Q2 | 62.15 Million HKD | 0.0% |
| 2020 Q4 | 65.36 Million HKD | 0.0% |
| 2020 FY | 110.02 Million HKD | -24.85% |
| 2019 FY | 146.41 Million HKD | 39.71% |
| 2018 FY | 104.8 Million HKD | 10.28% |
| 2017 FY | 95.03 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -570.963% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 95.755% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -361.272% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | 53.699% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -858.227% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | 72.271% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | 86.666% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | 67.45% |
| PuraPharm Corporation Limited | 216.62 Million HKD | 24.352% |
| SSY Group Limited | 1.98 Billion HKD | 91.727% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | 42.97% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 99.442% |